| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Vertex Inc.: Vertex, Inc. Announces Closing of Upsized Offering of $345 Million Convertible Senior Notes | 1 | GlobeNewswire (USA) | ||
| Fr | $100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs | 4 | Benzinga.com | ||
| Fr | Vertex Pharmaceuticals: Vertex Announces European Commission Approval for KALYDECO to Treat Infants With Cystic Fibrosis Ages 1 Month and Older | 248 | Business Wire | KALYDECO is the first and only medicine approved in the EU in this age group to treat the underlying cause of cystic fibrosis for specific mutations in the CFTR gene - Vertex Pharmaceuticals... ► Artikel lesen | |
| Fr | Vertex Inc.: Vertex wird Mitglied der Oracle ISV Accelerator for SaaS-Initiative | 179 | GlobeNewswire (Deutschland) | Vertex bietet seinen Kunden optimierte Geschäftsprozesse und -ergebnisse durch die Integration von Steuern in und um Oracle Fusion Cloud ApplicationsKING OF PRUSSIA, Pennsylvania, April 26, 2024nutzt... ► Artikel lesen | |
| Do | (VRTX) - Analyzing Vertex Pharmaceuticals' Short Interest | 11 | Benzinga.com | ||
| Do | The Coros Vertex 2S is the most accurate, longest-lasting sports watch I've seen yet | 1 | ZDNet.com | ||
| Mi | Vertex und Treefrog Therapeutics geben Lizenzvereinbarung und Zusammenarbeit zur Optimierung der Produktion der Zelltherapien von Vertex für Typ-1-Diabetes bekannt | 201 | PR Newswire | • Vertex erhält eine exklusive Lizenz für TreeFrogs C-Stem Herstellungstechnologie bei Typ-1-Diabetes • TreeFrog und Vertex arbeiten gemeinsam an der Weiterentwicklung von vollständig differenzierten... ► Artikel lesen | |
| Mi | Vertex Inc.: Vertex Selected to Join Oracle ISV Accelerator for SaaS Initiative | 195 | GlobeNewswire (Europe) | Vertex offers customers an optimized business operations and outcomes experience by integrating tax in and around Oracle Fusion Cloud ApplicationsKING OF PRUSSIA, Pa., April 24, 2024integrations, Vertex... ► Artikel lesen | |
| Mi | Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche: Evaluate | 20 | FiercePharma | ||
| Mi | Vertex prices $300M convertible senior notes | 1 | Seeking Alpha | ||
| Mi | Vertex Inc.: Vertex, Inc. Announces Pricing of Upsized $300 Million Convertible Senior Notes Offering | 1 | GlobeNewswire (USA) | ||
| 23.04. | Cracking The Code: Understanding Analyst Reviews For Vertex | 1 | Benzinga.com | ||
| 23.04. | Alpine's data room was the most exclusive club in biotech. Then Vertex became the VIP | 11 | FierceBiotech | ||
| 23.04. | Vertex Obtains Exclusive License to TreeFrog's C-Stem Technology | 5 | Contract Pharma | ||
| 23.04. | Vertex drops on planned convertible debt offering | 2 | Reuters | ||
| 23.04. | Vertex in-licenses cell therapy technology for diabetes candidates | 4 | Seeking Alpha | ||
| 23.04. | Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies | 3 | Zacks | ||
| 23.04. | Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy? | 6 | The Motley Fool | ||
| 23.04. | Vertex drops 2.5% after providing prelim Q1 numbers | 1 | Seeking Alpha | ||
| 23.04. | Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology, C-Stem | 281 | AFX News | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) announced Tuesday that it has obtained an exclusive license from TreeFrog Therapeutics, a French-based biotech company... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 3.947 |
| TESLA | 3.302 |
| DEUTSCHE BANK | 2.473 |
| NEL | 1.844 |
| BYD | 1.698 |
| NVIDIA | 1.392 |
| BAYER | 1.250 |
| TUI | 1.248 |
| SUPER MICRO COMPUTER | 1.046 |
| RHEINMETALL | 972 |
| AIXTRON SE | 890 |
| COMMERZBANK | 795 |
| PHILIPS | 773 |
| BASF | 742 |
| RWE | 725 |
| MERCEDES-BENZ | 692 |
| JINKOSOLAR | 686 |
| META PLATFORMS | 643 |
| PLUG POWER | 637 |
| AMAZON | 636 |
| THYSSENKRUPP | 620 |
| DELIVERY HERO | 614 |
| HEIDELBERGER DRUCK | 595 |
| SIEMENS ENERGY | 576 |
| RENK GROUP | 534 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
